UK consensus on normal tissue dose constraints for stereotactic radiotherapy
Six UK studies investigating stereotactic ablative radiotherapy (SABR) are currently open. Many of these involve the treatment of oligometastatic disease at different locations in the body. Members of all the trial management groups collaborated to generate a consensus document on appropriate organ...
Главные авторы: | Hanna, G, Murray, L, Patel, R, Jain, S, Aitken, K, Franks, K, van As, N, Tree, A, Hatfield, P, Harrow, S, McDonald, F, Ahmed, M, Saran, F, Webster, G, Khoo, V, Landau, D, Eaton, D, Hawkins, M |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
Elsevier
2017
|
Схожие документы
-
UK stereotactic ablative radiotherapy trials normal tissue dose constraints tolerance consensus
по: Hanna, G, и др.
Опубликовано: (2016) -
Stereotactic body radiotherapy for liver metastases.
по: Aitken, K, и др.
Опубликовано: (2015) -
Stereotactic body radiotherapy for oligometastases.
по: Tree, A, и др.
Опубликовано: (2013) -
A randomised trial of conventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
по: Khoo, V, и др.
Опубликовано: (2018) -
CORE: A randomised trial of COnventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
по: Khoo, V, и др.
Опубликовано: (2017)